SUBSCRIBE
SUBSCRIBE

Synexa Life Sciences

Synexa Life Sciences is a biomarker and bioanalytical lab CRO, specialising in the development, validation and delivery of a wide range of complex and custom-designed assays.

With a team of over 200 staff across three global laboratory locations; Manchester, Turku (Finland) and Cape Town, we provide innovative solutions to support our customers to achieve their clinical milestones.

Our main areas of expertise include biomarker identification and development, large and small molecule clinical bioanalysis, (soluble) biomarker analysis (utilising MSD, LC-MS/MS, ELISA, RIA, fluorescence and luminescence-based technologies), cell biology (including flow cytometry, ELISpot and Fluorospot) and genomic services to support clinical trials and translational studies.

We pride ourselves on our deep scientific expertise and ability to tackle complex problems, translating them into robust and reliable assays to support clinical trial sample analysis.

NEWS
Houston, Texas, downtown city skyline over Root Square
Job Trends
10 Companies Hiring in Texas Now
Looking for a biopharma job in Texas? Check out the BioSpace list of 10 companies hiring life sciences professionals like you.
April 8, 2026
 · 
1 min read
 · 
Angela Gabriel
Stylish gold office chair standing on black award podium over black background. Concept of success, being number one in business and victory celebration. 3d rendering
C-suite
Novavax Shareholder Vows To Fight CEO Pay Package, End ‘Dogmatic Leadership’
“Your tenure has overseen a DESTRUCTION of shareholder value—a direct result of chronic operational shortcomings and failures on fiduciary duty,” Shah Capital wrote to Novavax’s leadership in an open letter published Wednesday.
April 8, 2026
 · 
3 min read
 · 
Annalee Armstrong
fail the exam, bad work, paper recycling, a crumpled sheet of paper is thrown into the wastebasket
Dermatology
Insmed Scraps Skin Plans for Lung Disease Drug as Competitors Make Headway
After a Phase 2 flop, Brinsupri exits the race to market for the chronic skin disease hidradenitis suppurativa, but other companies, including Incyte, Novartis and UCB, have recently notched clinical and regulatory victories.
April 8, 2026
 · 
2 min read
 · 
Tristan Manalac
Large sharp meat cleaver sticking out of a rustic wood cutting board on a grey background. 3d render.
Mergers & acquisitions
Merck Chopped $1B Off Terns’ Offer After Seeing Updated Leukemia Data
Another bidder, which remains unidentified, dropped out of the bidding process. Analysts at William Blair now think it unlikely that another suitor could offer a counter-proposal to Merck’s outstanding $6.7 billion acquisition offer.
April 8, 2026
 · 
3 min read
 · 
Tristan Manalac
Podcast
Lilly’s Foundayo Nod Launches New Battle With Novo, M&A Mania Continues, Tariffs Hit Pharma
The approval of Eli Lilly’s oral obesity drug officially ignites an intense competition with Novo Nordisk’s oral Wegovy; Gilead Sciences and Neurocrine Biosciences keep the M&A train chugging; Trump hits pharma with his long promised tariffs, and the FDA proposes many changes with 2027 budget.
April 8, 2026
 · 
1 min read
 · 
Heather McKenzie
Illustration of businessperson with ladder sizing up very tall steps
Career Advice
When a Good Boss Is Bad for Your Career
Some bosses stretch you. Others make work more bearable. Both can earn your loyalty. Only one is building your future. Leadership coach Angela Justice explains how to tell the difference.
April 8, 2026
 · 
4 min read
 · 
Angela Justice
Prompt Engineering in AI Chatbot llm Application, Robotic Assistant with laptop dashboard chat message and Big data concept illustration
Insights
As CGT Manufacturing Scales Up, Automation and Collaboration Become Essential
As cell and gene therapy developers face rising pressure to produce therapies faster and at lower cost, the industry is leaning on robotics, digital systems and partnerships to bridge the gap between innovation and delivery.
April 8, 2026
 · 
3 min read
 · 
Jennifer C. Smith-Parker
highly qualified female specialist in demand on the labor market. human hands give money and offers of job to confident businesswoman. vector illustration
Women’s health
Daré’s CEO Wants Everyone To Invest in Women’s Health, Starting With Her Company
As Daré Biosciences approaches a pivotal year with a key product launch ahead, the company kicked off an open public offering, providing a chance for individuals to get involved for as little as $250.
April 8, 2026
 · 
3 min read
 · 
Annalee Armstrong
Yellow paper airplane flying in straight line over black labyrinth on light background, symbolizing leadership, business strategy, and innovation. 3D Rendering
Opinion
To Survive the Downturn, Biotechs Must Return to Basics
In the current geopolitical and capital-market uncertainty, biotechs that have not mastered the basics are the ones struggling the most. Here’s how—and why—to get the details right.
April 8, 2026
 · 
5 min read
 · 
Driscoll R. Ugarte
Load More
Visit website
Email Us
IN THE PRESS
Press Releases
Waters Sets a New Benchmark for Robustness and Sensitivity for High-Throughput Labs with the Xevo TQ Absolute XR Mass Spectrometer
June 2, 2025
 · 
4 min read
BioMidwest
Inotiv, Inc. Announces New Site Openings and Expansions Supporting Additional Capacity and Service Offerings
December 8, 2022
 · 
4 min read
Business
Parexel Announces Strategic Collaboration with Synexa Life Sciences and Drawbridge Health for COVID-19 Clinical Serology Testing Solution
November 2, 2020
 · 
4 min read
JOBS